Navigation Links
Merrimack Pharmaceuticals' Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
Date:4/8/2013

s were harvested 24 hours after initiating treatment post-randomization and at the end of the study when all treatment arms developed resistance.

Sanofi and Merrimack entered into an exclusive, global license and collaboration agreement for MM-121 in 2009.

About Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six targeted therapeutic oncology candidates in clinical development.

Forward-Looking Statement
To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include any statements about Merrimack's strategy, future operations, future financial position and future expectations and plans and prospects for Merrimack, and any other statements containing the words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. In this press release, Merrimack's forward-looking statements include statements about the potential effectiveness of its drug candidates in new indications and its ability to translate preclinical data into future clinical success. Such forward-looking statements involve substantial risks and uncertainties that could cause Merrimack's clinical development programs, future results, performance or achievements to differ significantly from those expressed or implie
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
2. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
3. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
4. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
5. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
6. Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
7. Regeneron Pharmaceuticals Announces Expansion in New Yorks Hudson Valley
8. Valeant Pharmaceuticals Provides Update to Recent Event
9. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
10. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
11. European Nuclear Medicine / Radiopharmaceuticals Market Worth by Reach $1.6 Billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 TWi Pharmaceuticals, Inc. ... TWi Pharmaceuticals USA , has obtained ... United States.  It has been in close contact with ... expects to have its own label specialty generic products ... the U.S. pharma market. According to IMS ...
(Date:4/16/2015)... , April 16, 2015 A drug commonly ... eyesight of people with multiple sclerosis (MS), according to a ... Academy of Neurology,s 67th Annual Meeting in Washington, ... "About half of people with MS experience at some ... in which the nerve carrying vision from the eye to ...
(Date:4/16/2015)... 16, 2015  Amgen (NASDAQ: AMGN ) today ... results on Tuesday, April 21, 2015, after the close ... followed by a conference call with the investment community ... Amgen will be Robert A. Bradway , chairman ... senior management team. Live audio of the ...
Breaking Medicine Technology:Epilepsy Drug May Preserve Eyesight for People with MS 2Amgen Announces Webcast Of 2015 First Quarter Financial Results 2
...  Russia,s first Leksell Gamma Knife® Perfexion™ system has found ... just a five-minute car ride from Moscow,s Red Square. ... first Perfexion patient, receiving Gamma Knife® radiosurgery to treat ... months later, the Institute has treated more than 400 ...
... ENMD ), a clinical-stage pharmaceutical company developing therapeutics ... Ph.D has joined the Board of Directors as Executive Chairman ... of the Board of Directors. (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO ... CEO and Chairman of OriGene Technologies, Inc. He also is ...
Cached Medicine Technology:Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion 2Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion 3Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 2Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 3Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 4
(Date:4/19/2015)... Carinsurancehints.com has released a new blog post providing a simple ... benefits . , Drivers who were involved in an ... for claiming auto insurance benefits. Exchanging insurance information is important, ... of the damages. The newly released blog post explains how ... Drivers can compare online rates and find the best prices ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 The American ... up with PROSHRED Security (“PROSHRED”) to host its second ... to shred their personal documents in order to raise ... prevention. , The June 6th event is being held ... – 2pm local time. The time will vary at ...
(Date:4/19/2015)... WI (PRWEB) April 19, 2015 HealthPostures, ... announces that it will exhibit it’s pioneering ergonomics ... Expo and the Iowa-Illinois Safety Council Professional Development Conference ... and the TaskMate EZ are used in volume by ... facilities. , Built to clamp to a desk, ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog ... cheaper during Spring. , Spring can be a ... should make sure they compare the newest policies before ... learn more about Spring car insurance offers by reading ... quotes are becoming more and more popular. Many insurance ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post ... . , Clients can review important auto insurance ... environment provides important advantages for clients who need affordable ... do not have coverage for their vehicles can purchase ... or hour. Many agencies offer important discounts and drivers ...
Breaking Medicine News(10 mins):Health News:An Online Guide About Claiming Auto Insurance Benefits After an Accident 2Health News:2015 Annual Nationwide "Shred Cancer" Shredding Event 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2
... patients on urinary catheters longer than necessary, increasing their ... a new study published in the Joint Commission Journal ... a simple reminder note put by the nursing staff ... showed that about 25 percent of hospital patients at ...
... key to extend the lifespan of many species through ... Boston and University of California, Davis, screened for genes ... to the study published today in the advance online ... gene do not live longer when subjected to calorie ...
... a new study says//. ,Phillip Marucha, and his ... a study of laboratory mice, found that psychological stress, ... by more than 45 percent, reports science portal eurekalert.org. ... accounted for the slow recovery, it said. ...
... the insects are itchy and swollen, rather than being tender//. ... tenderness may be a sign the bug bite is becoming ... possible infection are redness extending beyond the immediate bug bite, ... site over time. The monsoon is the insect season that ...
... neurodegenerative and ultimately fatal disease// that slowly destroys the ... the ability to take care of themselves and require ... ,Based on findings of a recent study researchers say ... help slow the progression of Alzheimer's disease by reducing ...
... sure so many harried parents have time and again thought ... there is a flood of TV channels, but how many ... that on our fingertips. ,Now, adding parents is a ... TV. Other than helping them for educational purposes, it harms ...
Cached Medicine News:Health News:Patients Are Given Catheter Longer Than Necessary 2Health News:Genes to Extend Longevity Discovered 2Health News:Stop Watching TV: Toddler Development Affected 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: